Naltrexone maintenance treatment

Amy Gibson; Alison Ritter

Naltrexone maintenance treatment

Amy Gibson
, Alison Ritter

Research output: Chapter in Book / Conference Paper › Chapter

Abstract

Naltrexone was first registered in the US in 19841 and today is available in many countries as a treatment for both heroin and alcohol dependence. This chapter reviews the safety, efficacy, and effectiveness of naltrexone as a maintenance treatment for opioid dependence. The safety and efficacy of naltrexone as a withdrawal intervention for heroin detoxification was discussed in Chapter 3.

Original language	English
Title of host publication	Pharmacotherapies for the Treatment of Opioid Dependence : Efficacy, Cost-effectiveness, and Implementation Guidelines
Editors	Richard P. Mattick, Robert Ali, Nicholas Lintzeris
Place of Publication	U.K.
Publisher	InformaHealthcare
Pages	252-281
Number of pages	30
ISBN (Electronic)	9780203414088
ISBN (Print)	9781841844008
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@inbook{22ef88584e5d4c3abe0a7f98c5504c0a,

title = "Naltrexone maintenance treatment",

abstract = "Naltrexone was first registered in the US in 19841 and today is available in many countries as a treatment for both heroin and alcohol dependence. This chapter reviews the safety, efficacy, and effectiveness of naltrexone as a maintenance treatment for opioid dependence. The safety and efficacy of naltrexone as a withdrawal intervention for heroin detoxification was discussed in Chapter 3.",

author = "Amy Gibson and Alison Ritter",

year = "2009",

language = "English",

isbn = "9781841844008",

pages = "252--281",

editor = "Mattick, \{Richard P.\} and Robert Ali and Nicholas Lintzeris",

booktitle = "Pharmacotherapies for the Treatment of Opioid Dependence : Efficacy, Cost-effectiveness, and Implementation Guidelines",

publisher = "InformaHealthcare",

}

TY - CHAP

T1 - Naltrexone maintenance treatment

AU - Gibson, Amy

AU - Ritter, Alison

PY - 2009

Y1 - 2009

N2 - Naltrexone was first registered in the US in 19841 and today is available in many countries as a treatment for both heroin and alcohol dependence. This chapter reviews the safety, efficacy, and effectiveness of naltrexone as a maintenance treatment for opioid dependence. The safety and efficacy of naltrexone as a withdrawal intervention for heroin detoxification was discussed in Chapter 3.

AB - Naltrexone was first registered in the US in 19841 and today is available in many countries as a treatment for both heroin and alcohol dependence. This chapter reviews the safety, efficacy, and effectiveness of naltrexone as a maintenance treatment for opioid dependence. The safety and efficacy of naltrexone as a withdrawal intervention for heroin detoxification was discussed in Chapter 3.

UR - http://handle.uws.edu.au:8081/1959.7/528130

M3 - Chapter

SN - 9781841844008

SP - 252

EP - 281

BT - Pharmacotherapies for the Treatment of Opioid Dependence : Efficacy, Cost-effectiveness, and Implementation Guidelines

A2 - Mattick, Richard P.

A2 - Ali, Robert

A2 - Lintzeris, Nicholas

PB - InformaHealthcare

CY - U.K.

ER -

Naltrexone maintenance treatment

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this